Cas:58142-49-7 3-Chloroisoquinolin-5-amine manufacturer & supplier

We serve Chemical Name:3-Chloroisoquinolin-5-amine CAS:58142-49-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Chloroisoquinolin-5-amine

Chemical Name:3-Chloroisoquinolin-5-amine
CAS.NO:58142-49-7
Synonyms:3-chloroisoquinoline-5-ylamine;5-Isoquinolinamine, 3-chloro-;QC-3983;3-Chloro-5-isoquinolinamine;3-chloro-5-amino-isoquinoline;5-Isoquinolinamine,3-chloro;5-AMINO-3-CHLOROISOQUINOLINE;3-Chloroisoquinolin-5-amine
Molecular Formula:C9H7ClN2
Molecular Weight:178.618
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:372.6±27.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.712
PSA:38.91000
Exact Mass:178.029770
LogP:1.35

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-chloroisoquinoline-5-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Chloroisoquinolin-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-chloroisoquinoline-5-ylamine Use and application,3-Chloro-5-isoquinolinamine technical grade,usp/ep/jp grade.


Related News: The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked incentive scheme for active pharmaceutical ingredients, an official release said on Thursday. (4R,5S,7R,9R)-2-((13,24,33,43,53,63-hexaoxin-2-yl)-13-tetraoxidaneyl)-5H-23,44,54,64,74,94-5,7-epoxypentaoxola[1,2]hexaoxane-4,5,6,6,7,9-hexaol manufacturers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. (E)-6-chloro-7,7-dimethoxy-hept-5-en-2-one suppliers One way of leveraging the many benefits of biocatalysis is to partner with an API CDMO offering comprehensive expertise and experience in developing and implementing such technology in GMP commercial production. 1,1,2-Triphenyl-1,2,2-triaethoxycarbonyl-aethan vendor & factory.